DK0995747T3 - Substituterede sulfonylphenylheterocykler som cyclooxygenase-2- og 5-lipoxygenase-inhibitorer - Google Patents
Substituterede sulfonylphenylheterocykler som cyclooxygenase-2- og 5-lipoxygenase-inhibitorerInfo
- Publication number
- DK0995747T3 DK0995747T3 DK00100201T DK00100201T DK0995747T3 DK 0995747 T3 DK0995747 T3 DK 0995747T3 DK 00100201 T DK00100201 T DK 00100201T DK 00100201 T DK00100201 T DK 00100201T DK 0995747 T3 DK0995747 T3 DK 0995747T3
- Authority
- DK
- Denmark
- Prior art keywords
- cyclooxygenase
- heterocycles
- lipoxygenase inhibitors
- sulfonylphenyl
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/460,324 US5643933A (en) | 1995-06-02 | 1995-06-02 | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0995747T3 true DK0995747T3 (da) | 2002-11-25 |
Family
ID=23828245
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00100201T DK0995747T3 (da) | 1995-06-02 | 1996-05-31 | Substituterede sulfonylphenylheterocykler som cyclooxygenase-2- og 5-lipoxygenase-inhibitorer |
DK96917888T DK0828736T3 (da) | 1995-06-02 | 1996-05-31 | Substituerede sulfonylphenylheterocycler som cyclooxygenase-2- og 5-lipoxygenase-inhibitorer |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96917888T DK0828736T3 (da) | 1995-06-02 | 1996-05-31 | Substituerede sulfonylphenylheterocycler som cyclooxygenase-2- og 5-lipoxygenase-inhibitorer |
Country Status (11)
Country | Link |
---|---|
US (1) | US5643933A (de) |
EP (2) | EP0828736B1 (de) |
AT (2) | ATE246188T1 (de) |
AU (1) | AU6027996A (de) |
CA (1) | CA2223091A1 (de) |
DE (2) | DE69629290T2 (de) |
DK (2) | DK0995747T3 (de) |
ES (2) | ES2181614T3 (de) |
HK (1) | HK1027802A1 (de) |
PT (2) | PT828736E (de) |
WO (1) | WO1996038442A1 (de) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5633272A (en) * | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
CA2223154A1 (en) | 1995-06-02 | 1996-12-05 | G.D. Searle & Co. | Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
US6512121B2 (en) | 1998-09-14 | 2003-01-28 | G.D. Searle & Co. | Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
CA2246265A1 (en) | 1996-02-13 | 1997-08-21 | G.D. Searle & Co. | Combinations having immunosuppressive effects, containing cyclooxygenase-2-inhibitors and 5-lipoxygenase inhibitors |
US5908858A (en) | 1996-04-05 | 1999-06-01 | Sankyo Company, Limited | 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses |
US6677364B2 (en) * | 1998-04-20 | 2004-01-13 | G.D. Searle & Co. | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
DE69717281T2 (de) | 1996-08-14 | 2003-09-04 | G.D. Searle & Co., Chicago | Kristalline form von 4-[5-methyl-3-phenylisoxazol-4-yl]benzolsulfonamid |
FR2753449B1 (fr) * | 1996-09-13 | 1998-12-04 | Union Pharma Scient Appl | Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique |
WO1998043648A1 (en) * | 1997-04-03 | 1998-10-08 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia |
NZ500141A (en) * | 1997-04-18 | 2002-05-31 | G | Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders |
TW492959B (en) * | 1997-04-18 | 2002-07-01 | Merck & Co Inc | Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors |
US6127545A (en) * | 1997-04-18 | 2000-10-03 | Merck & Co., Inc. | Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitors |
US6130334A (en) * | 1998-04-15 | 2000-10-10 | Merck & Co., Inc. | Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitors |
FR2769311B1 (fr) * | 1997-10-07 | 1999-12-24 | Union Pharma Scient Appl | Nouveaux derives 3,4-diarylthiazolin-2-one ou -2-thione, leurs procedes de preparation et leurs utilisations en therapeutique |
US7041694B1 (en) | 1997-12-17 | 2006-05-09 | Cornell Research Foundation, Inc. | Cyclooxygenase-2 inhibition |
CA2320290A1 (en) | 1998-06-08 | 1999-12-16 | Advanced Medicine, Inc. | Multibinding inhibitors of cyclooxygenase-2 |
TW477789B (en) | 1998-09-03 | 2002-03-01 | Japan Tobacco Inc | Production method of oxazole compound |
SA99191255B1 (ar) | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | مركبات سيليكوكسيب celecoxib |
ES2159479B1 (es) * | 1999-10-25 | 2002-05-01 | Menarini Lab | Nuevos indazoles como inhibidores de la ciclooxigenasa-ii |
PL351944A1 (en) * | 1999-12-08 | 2003-07-14 | Pharmacia Corp | Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
PE20020146A1 (es) * | 2000-07-13 | 2002-03-31 | Upjohn Co | Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2) |
US7115565B2 (en) * | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
US7695736B2 (en) | 2001-04-03 | 2010-04-13 | Pfizer Inc. | Reconstitutable parenteral composition |
UA80682C2 (en) * | 2001-08-06 | 2007-10-25 | Pharmacia Corp | Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition |
US20050101563A1 (en) * | 2001-08-14 | 2005-05-12 | Pharmacia Corporation | Method and compositions for the treatment and prevention of pain and inflammation |
US20030114416A1 (en) * | 2001-08-14 | 2003-06-19 | Pharmacia Corporation | Method and compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
AR038957A1 (es) | 2001-08-15 | 2005-02-02 | Pharmacia Corp | Terapia de combinacion para el tratamiento del cancer |
US20030212138A1 (en) * | 2002-01-14 | 2003-11-13 | Pharmacia Corporation | Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
US20030220374A1 (en) * | 2002-01-14 | 2003-11-27 | Pharmacia Corporation | Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors |
EP1494664A2 (de) * | 2002-04-18 | 2005-01-12 | Pharmacia Corporation | Kombinationen aus cox-2-hemmer und anderen agenten zur behandlung von morbus parkinsonian |
MXPA04010186A (es) * | 2002-04-18 | 2005-02-03 | Pharmacia Corp | Monoterapia para el tratamiento de la enfermedad de parkinson con inhibidor (es) de la ciclooxigenasa-2 (cox 2). |
HUE039881T2 (hu) | 2002-05-09 | 2019-02-28 | Brigham & Womens Hospital Inc | 1L1RL-1, mint egy kardiovaszkuláris betegség-marker |
AU2003241603B2 (en) * | 2002-05-24 | 2008-05-15 | Pharmacia Corporation | Synthesis of diaryl pyrazoles |
US20040147581A1 (en) * | 2002-11-18 | 2004-07-29 | Pharmacia Corporation | Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy |
DE60332387D1 (de) | 2002-12-13 | 2010-06-10 | Warner Lambert Co | Alpha-2-delta-ligand zur behandlung vonsymptomen der unteren harnwege |
US20040204411A1 (en) * | 2002-12-17 | 2004-10-14 | Pharmacia Corporation | Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of reboxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof |
US20040235925A1 (en) * | 2002-12-17 | 2004-11-25 | Pharmacia Corporation | Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof |
ES2394782T3 (es) * | 2003-05-07 | 2013-02-05 | Osteologix A/S | Composición con estroncio y vitamina D para la profilaxis y/o tratamiento de afecciones de cartílagos y/o huesos |
PL1745791T3 (pl) * | 2003-05-07 | 2013-11-29 | Osteologix As | Leczenie chorób chrząstki/kości za pomocą rozpuszczalnych w wodzie soli strontu |
EP1663184A2 (de) | 2003-08-29 | 2006-06-07 | The Brigham And Women's Hospital, Inc. | Hydantoin-derivate als hemmer der zellnekrose |
EP1697746B1 (de) | 2003-12-05 | 2012-02-22 | The Cleveland Clinic Foundation | Risikomarker für eine herzkreislaufkrankheit |
US7449462B2 (en) | 2004-01-22 | 2008-11-11 | Pfizer, Inc. | Triazole derivatives which inhibit vasopressin antagonistic activity |
CA2624601C (en) | 2004-10-06 | 2018-07-03 | The Brigham And Women's Hospital, Inc. | Relevance of achieved levels of markers of systemic inflammation following treatment |
US8119358B2 (en) | 2005-10-11 | 2012-02-21 | Tethys Bioscience, Inc. | Diabetes-related biomarkers and methods of use thereof |
CN101304993A (zh) * | 2005-11-07 | 2008-11-12 | Irm责任有限公司 | 作为ppar调节剂的化合物和组合物 |
PT3279663T (pt) | 2006-03-15 | 2021-09-24 | Brigham & Womens Hospital Inc | Utilização de gelsolina para o diagnóstico e tratamento de doenças inflamatórias |
US20080057590A1 (en) | 2006-06-07 | 2008-03-06 | Mickey Urdea | Markers associated with arteriovascular events and methods of use thereof |
US8128460B2 (en) * | 2006-09-14 | 2012-03-06 | The Material Works, Ltd. | Method of producing rust inhibitive sheet metal through scale removal with a slurry blasting descaling cell |
RS51940B (en) | 2006-12-22 | 2012-02-29 | Recordati Ireland Limited | Combined TH2δ LIGANAD THERAPY AND NSAID FOR LOWER URINARY TRACT DISORDERS |
JP2010516679A (ja) * | 2007-01-19 | 2010-05-20 | マリンクロット インコーポレイテッド | 診断用および治療用シクロオキシゲナーゼ−2結合リガンド |
AU2008242764B2 (en) | 2007-04-18 | 2013-10-24 | Tethys Bioscience, Inc. | Diabetes-related biomarkers and methods of use thereof |
BRPI0814542A2 (pt) | 2007-07-12 | 2014-09-30 | Tragara Pharmaceuticals Inc | Métodos e composições para o tratamento de câncer, tumores e desordens relacionadas a tumores |
GB2462022B (en) | 2008-06-16 | 2011-05-25 | Biovascular Inc | Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof |
SG182821A1 (en) | 2010-02-01 | 2012-08-30 | Hospital For Sick Children | Remote ischemic conditioning for treatment and prevention of restenosis |
SG10201502031XA (en) | 2010-03-31 | 2015-05-28 | Hospital For Sick Children | Use of remote ischemic conditioning to improve outcome after myocardial infarction |
US20130302837A1 (en) * | 2011-01-14 | 2013-11-14 | Hal Allergy Holding B.V. | Immunoassay for Direct Determination of Antigen Content of Products Comprising Adjuvant-Coupled-Antigen Particles |
US9265772B2 (en) | 2012-05-11 | 2016-02-23 | Reset Therapeutics, Inc. | Carbazole-containing sulfonamides as cryptochrome modulators |
CN102839200B (zh) * | 2012-05-25 | 2015-03-18 | 杭州师范大学 | 酶催化合成2,4,5-三取代的咪唑环类衍生物的方法 |
AU2013302468B2 (en) * | 2012-08-16 | 2017-08-24 | Janssen Pharmaceutica Nv | Substituted pyrazoles as N-type calcium channel blockers |
JP2015527365A (ja) | 2012-08-21 | 2015-09-17 | オルソ−クリニカル ダイアグノスティクス,インコーポレイティド | パリペリドンに対する抗体及びその使用 |
CA2882563C (en) | 2012-08-21 | 2022-11-29 | Eric Hryhorenko | Antibodies to risperidone haptens and use thereof |
US9765052B2 (en) | 2013-02-20 | 2017-09-19 | Basf Se | Anthranilamide compounds, their mixtures and the use thereof as pesticides |
US9725452B2 (en) | 2013-03-15 | 2017-08-08 | Presidents And Fellows Of Harvard College | Substituted indoles and pyrroles as RIP kinase inhibitors |
US9453002B2 (en) | 2013-08-16 | 2016-09-27 | Janssen Pharmaceutica Nv | Substituted imidazoles as N-type calcium channel blockers |
TWI690521B (zh) | 2014-04-07 | 2020-04-11 | 美商同步製藥公司 | 作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類 |
CA3113353A1 (en) | 2018-09-19 | 2020-03-26 | Modernatx, Inc. | High-purity peg lipids and uses thereof |
US20220047518A1 (en) | 2018-09-19 | 2022-02-17 | Moderna TX, Inc. | Peg lipids and uses thereof |
CA3209491A1 (en) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5242940A (en) * | 1987-05-29 | 1993-09-07 | Ortho Pharmaceutical Corporation | Pharmacologically active N-1 and C-5 heterocyclic pyrazoles and method for synthesizing the same |
GB8927287D0 (en) * | 1988-12-23 | 1990-01-31 | Ici Plc | Cyclic ether derivatives |
US5234950A (en) * | 1988-12-23 | 1993-08-10 | Imperial Chemical Industries Plc | Tetrahydrofuran derivatives |
US5196419A (en) * | 1989-02-28 | 1993-03-23 | Imperial Chemical Industries Plc | Heterocyclic cyclic ethers |
US5234939A (en) * | 1990-03-27 | 1993-08-10 | Warner-Lambert Company | 3,5-di-tertiary-butyl-4-hydroxyphenyl imidazolyl methanones and related compounds as antiinflammatory agents |
US5179115A (en) * | 1990-06-21 | 1993-01-12 | Imperial Chemical Industries Plc | Bicyclic heterocyclic derivatives as 5-lipoxygenase inhibitors |
IE911919A1 (en) * | 1990-06-21 | 1992-01-01 | Zeneca Ltd | Bicyclic heterocyclic compounds |
GB9113137D0 (en) * | 1990-07-13 | 1991-08-07 | Ici Plc | Thioxo heterocycles |
IE913655A1 (en) * | 1990-11-06 | 1992-05-22 | Zeneca Ltd | Synergistic agents |
US5356898A (en) * | 1991-01-31 | 1994-10-18 | Warner-Lambert Company | Substituted 4,6-di-tertiary-butyl 5-hydroxy-pyrimidines |
US5308852A (en) * | 1992-06-29 | 1994-05-03 | Merck Frosst Canada, Inc. | Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
US5354865A (en) * | 1992-09-10 | 1994-10-11 | Abbott Laboratories | Phenylmethyl derivatives having lipoxygenase inhibitory activity |
US5604260A (en) * | 1992-12-11 | 1997-02-18 | Merck Frosst Canada Inc. | 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 |
EP0759432A1 (de) * | 1993-01-15 | 1997-02-26 | G.D. Searle & Co. | Verwendung von 3,4-Diarylfuranen und deren Analoga enthaltende Medikamente zur Behandlung von Hauterkrankungen |
US5409944A (en) * | 1993-03-12 | 1995-04-25 | Merck Frosst Canada, Inc. | Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase |
WO1994026731A1 (en) * | 1993-05-13 | 1994-11-24 | Merck Frosst Canada Inc. | 2-substituted-3,4-diarylthiophene derivatives as inhibitors of cyclooxygenase |
US5380738A (en) * | 1993-05-21 | 1995-01-10 | Monsanto Company | 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents |
US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
US5298521A (en) * | 1993-08-30 | 1994-03-29 | Ortho Pharmaceutical Corporation | 1,5-diphenyl-3-pyrazolylalkyl-N-hydroxydithiocaramates, compositions and use |
US5344991A (en) * | 1993-10-29 | 1994-09-06 | G.D. Searle & Co. | 1,2 diarylcyclopentenyl compounds for the treatment of inflammation |
US5401765A (en) * | 1993-11-30 | 1995-03-28 | G. D. Searle | 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders |
US5393790A (en) * | 1994-02-10 | 1995-02-28 | G.D. Searle & Co. | Substituted spiro compounds for the treatment of inflammation |
WO1995030669A1 (en) * | 1994-05-06 | 1995-11-16 | Zeneca Limited | Ether derivatives and pharmaceutical compositions containing them |
-
1995
- 1995-06-02 US US08/460,324 patent/US5643933A/en not_active Expired - Fee Related
-
1996
- 1996-05-31 DE DE69629290T patent/DE69629290T2/de not_active Expired - Fee Related
- 1996-05-31 PT PT96917888T patent/PT828736E/pt unknown
- 1996-05-31 DK DK00100201T patent/DK0995747T3/da active
- 1996-05-31 DK DK96917888T patent/DK0828736T3/da active
- 1996-05-31 AT AT96917888T patent/ATE246188T1/de not_active IP Right Cessation
- 1996-05-31 WO PCT/US1996/008183 patent/WO1996038442A1/en active IP Right Grant
- 1996-05-31 AT AT00100201T patent/ATE221885T1/de not_active IP Right Cessation
- 1996-05-31 EP EP96917888A patent/EP0828736B1/de not_active Expired - Lifetime
- 1996-05-31 ES ES00100201T patent/ES2181614T3/es not_active Expired - Lifetime
- 1996-05-31 EP EP00100201A patent/EP0995747B1/de not_active Expired - Lifetime
- 1996-05-31 CA CA002223091A patent/CA2223091A1/en not_active Abandoned
- 1996-05-31 ES ES96917888T patent/ES2205035T3/es not_active Expired - Lifetime
- 1996-05-31 DE DE69622894T patent/DE69622894T2/de not_active Expired - Fee Related
- 1996-05-31 PT PT00100201T patent/PT995747E/pt unknown
- 1996-05-31 AU AU60279/96A patent/AU6027996A/en not_active Abandoned
-
2000
- 2000-08-21 HK HK00105257A patent/HK1027802A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2223091A1 (en) | 1996-12-05 |
EP0995747B1 (de) | 2002-08-07 |
HK1027802A1 (en) | 2001-01-23 |
PT828736E (pt) | 2003-12-31 |
DE69622894D1 (de) | 2002-09-12 |
EP0995747A1 (de) | 2000-04-26 |
PT995747E (pt) | 2002-12-31 |
ES2181614T3 (es) | 2003-03-01 |
US5643933A (en) | 1997-07-01 |
ATE221885T1 (de) | 2002-08-15 |
EP0828736A1 (de) | 1998-03-18 |
EP0828736B1 (de) | 2003-07-30 |
DK0828736T3 (da) | 2003-11-24 |
DE69622894T2 (de) | 2003-04-30 |
WO1996038442A1 (en) | 1996-12-05 |
DE69629290T2 (de) | 2004-04-22 |
AU6027996A (en) | 1996-12-18 |
ATE246188T1 (de) | 2003-08-15 |
DE69629290D1 (en) | 2003-09-04 |
ES2205035T3 (es) | 2004-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0995747T3 (da) | Substituterede sulfonylphenylheterocykler som cyclooxygenase-2- og 5-lipoxygenase-inhibitorer | |
NL300175I1 (nl) | Methylsulfonylfenyl-2-(5H)-furanonen als remmers van COX-2. | |
NO20032254L (no) | Forbindelser for inhibering av ekspresjon av VACM-I | |
FI956119A (fi) | Fenyyliheterosyklejä syklo-oksigenaasi-2-inhibiittoreina | |
EA199900853A1 (ru) | Замещенные производные бензопирана для лечения воспалительных процессов | |
DE122009000012I1 (de) | Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen. | |
ATE179610T1 (de) | Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten | |
EE9900565A (et) | Piperasiini derivaadid ja nende kasutamine põletikuvastaste vahenditena | |
ATE212343T1 (de) | 3,4-diaryl-2-hydroxy-2,5-dihydrofurane als wirkstoffvorstufen von cox-2 inhibitoren | |
ATE302002T1 (de) | Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit | |
ATE223376T1 (de) | Bisarylcyclobutenderivate als cyclooxygenasehemmer | |
WO2002064742A3 (en) | Compounds effecting neuron remodeling and assays for same |